Benzinga | Mar 1, 2021 04:07PM EST

FibroGen Q4 EPS $(0.64) Up From $(1.12) YoY, Sales $65.00M Up From $7.97M YoY

FibroGen (NASDAQ:FGEN) reported quarterly losses of $(0.64) per share. This is a 42.86 percent increase over losses of $(1.12) per share from the same period last year. The company reported $65.00 million in sales this quarter. This is a 715.15 percent increase over sales of $7.97 million the same period last year.